| Filed On | Filing |
|---|---|
| 18 Aug 2025 |
8-K/A: Results of Operations and Financial Condition
Miramar, FL – August 18, 2025 – HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disru... |
| 23 Aug 2024 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
This release has made a correction to a release issued under the same headline on August 14, 2024, by HCW Biologics, Inc. (NASDAQ: HCWB), to show the amount included in the condensed interim balance sheet for Cash and cash equivalents as... |
Loading...
